<DOC>
	<DOCNO>NCT01157559</DOCNO>
	<brief_summary>The aim study investigate efficacy safety ziprasidone patient first episode psychosis .</brief_summary>
	<brief_title>Efficacy Safety With Ziprasidone First-episode Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Patients meet DSMIV criterion first episode schizophrenia , schizophreniform disorder schizoaffective disorder Patients previously prescribe antipsychotic medication 2 week patient substanceinduced psychotic disorder , serious suicide attempt , neurological disorder , etc .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>